The AFC/Pfizer National Sickle Cell Research Program was established on November 14, 2017. It aims to advance patient care and clinical research on sickle cell disease.
Through this program, Canadian researchers will conduct clinical and psycho-social research on sickle cell disease that will include an evaluation of results. Grants will be awarded for clinical research, quality improvement, qualitative research, quality of life and educational projects in areas related to improving the quality of life for people with sickle cell disease.
Who is the program for?
Applications are open to researchers working on this disease. They are encouraged to submit research proposals in the following areas of interest, but not limited to:
- Vaso-occlusive crisis management in the Emergency Department;
- Clinical management of vaso-occlusive seizures;
- Adherence to prescribed treatments;
- Management of adolescents and young adults with sickle cell disease;
- Systemic racism is linked to sickle cell anemia.
How can I access these grants?
Grants available: two individual grants in the amount of $20,000 per year for up to two years and two additional grants in the amount of up to $5,000 each will be available. If a two-year grant is awarded, the second year of funding is contingent upon an indication of progress as described in the required progress report.